Rheumatoid arthritis

Under Federal Law we are unable to promote prescription products to the general public, however we are able to provide the consumer medicine information that is inserted into the packaging. Please use the lefthand navigation to access these info sheets in PDF format.

Mabthera (rituximab)

MabThera belongs to a group of medicines known as monoclonal antibodies. Monoclonal antibodies are proteins which specifically recognise and bind to another unique protein called an antigen. MabThera contains the active ingredient called rituximab. Rituximab is a monoclonal antibody. MabThera works by binding to an antigen on the surface of certain white blood cells known as B lymphocytes. During the process of binding to the antigen, the growth of the B lymphocytes is stopped. MabThera is used to treat rheumatoid arthritis. Rheumatoid arthritis is a disease of the joints, and B lymphocytes cause some of the symptoms you have.

Download MabThera CMI | Access Download Centre | www.rheumatoidarthritis.com.au